Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Other Accumulated Expenses Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Bioventus (BVS) Other Non-Current Assets (2021 - 2022)

Bioventus filings provide 2 years of Other Non-Current Assets readings, the most recent being $2.8 million for Q4 2022.

On a quarterly basis, Other Non-Current Assets fell 94.45% to $2.8 million in Q4 2022 year-over-year; TTM through Dec 2022 was $2.8 million, a 94.45% decrease, with the full-year FY2022 number at $2.8 million, down 94.45% from a year prior.
Other Non-Current Assets hit $2.8 million in Q4 2022 for Bioventus, down from $50.0 million in the prior quarter.
In the past five years, Other Non-Current Assets ranged from a high of $50.0 million in Q4 2021 to a low of $2.8 million in Q4 2022.